Evidence map›Paper›PMID 24664737›Full record

ArticleAdvances in experimental medicine and biology2014

Synergistic interaction of tubby and tubby-like protein 1 (Tulp1).

Nora Blanca Caberoy

Open access · greenAbstract read
In one paragraph

Article in Advances in experimental medicine and biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Nora Blanca CaberoySchool of Life Sciences, University of Nevada Las Vegas, 89154, Las Vegas, NV, USA, nora.caberoy@unlv.edu.
University of Nevada, Las Vegas · US

Funding

Molecular Mechanisms of Tubby and Tulp1 Mediated RPE PhagocytosisR00EY020865 · NEI · UNIVERSITY OF NEVADA LAS VEGAS · PI CABEROY, NORA BLANCA · 2012 to 2014
$730k
Molecular Mechanisms of Tubby and Tulp1 Mediated RPE PhagocytosisK99EY020865 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CABEROY, NORA BLANCA · 2011 to 2011
$90k
NEI NIH HHS 1K99EY020865NEI NIH HHS 4R00EY020865NEI NIH HHS K99 EY020865NEI NIH HHS R00 EY020865
6 · The paper itself

Abstract

Mutations in either tubby or tubby-like protein 1 (Tulp1) cause retinal degeneration with undefined mechanisms. We recently identified both proteins with unconventional secretion as novel MerTK-specific phagocytosis ligands for retinal pigment epithelium (RPE) cells. Using our newly-developed open reading frame (ORF) phage display as a technology for protein-protein interactions, we identified Tulp1 as a Tubby-binding protein. The interaction of tubby and Tulp1 was verified by yeast two-hybrid and protein pull-down assays. Tubby and Tulp1 form heterodimer or heterooligomer and their interaction was functionally revealed by their synergistic stimulation of RPE phagocytosis. Tubby and Tulp1 mediated phagocytosis through MerTK-dependent signaling with non-muscle myosin II redistribution leading to colocalization of phagocytosed vesicles with rearranged NMMIIA.

Indexed as

Adaptor Proteins, Signal TransducingCell Linec-Mer Tyrosine KinaseDimerizationEye ProteinsHumansMyosin Type IIPhagocytosisProtein Interaction Domains and MotifsProteinsProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRetinal DegenerationRetinal Pigment EpitheliumTwo-Hybrid System TechniquesAdaptor Proteins, Signal Transducingc-Mer Tyrosine KinaseEye ProteinsMERTK protein, humanMyosin Type IIProteinsProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesTUB protein, humanTULP1 protein, human

Identifiers

PMID24664737
PMCPMC4109626
OpenAlexW1604373814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.